P
PharmaCielo
Global company privately held and headquartered in canada
About PharmaCielo
PharmaCielo is a pioneering company in the medicinal cannabis sector, primarily operating out of Colombia. As the first company to hold Colombian licenses for cannabis with unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD), PharmaCielo has established itself as the largest licensed producer in the country. The company specializes in the cultivation and processing of medicinal grade cannabis oil extracts and related products, which are used to provide reliable and standardized relief and wellness formulas for patients, including those requiring higher levels of THC.
Read full description
PharmaCielo operates a vast facility featuring 12.1 hectares (1.3 million square feet) of open-air greenhouses dedicated to the initial cultivation of cannabis plants. These seedlings are then supplied to over 1,000 hectares (2,500 acres) of contract open-air greenhouses for final cultivation. The company is also in the process of constructing and commissioning a downstream processing facility to further enhance its production capabilities.
The business model of PharmaCielo revolves around the production and sale of high-quality medicinal cannabis oil extracts. By leveraging Colombia's favorable growing conditions, including a balanced day-night cycle, natural rainwater, and fertile soil, the company ensures the cultivation of premium cannabis plants. PharmaCielo generates revenue through the commercial sales of its cannabis oil extracts and related products, which commenced in 2019.
PharmaCielo serves a diverse range of clients, including patients seeking medicinal cannabis products for various health conditions. The company is committed to contributing to the economic growth of Colombia and supporting the local communities, particularly indigenous groups with a long history of cultivating cannabis for spiritual and medicinal purposes.
In summary, PharmaCielo is a leading supplier of naturally grown and processed medicinal grade cannabis oil extracts, operating with a strong commitment to quality, sustainability, and community involvement.
At a glance
- Founded
- 2014
- Headquarters
- Toronto, Canada
- Listing
- IPO 2018
- Sector
- Biotech & Life Sciences
Latest news
Press, funding announcements and product moves mentioning PharmaCielo.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Cormark Securities
Stifel
Echelon Wealth Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about PharmaCielo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PharmaCielo on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.